Procurement Summary
Country : USA
Summary : Nci Patterns of Care (Poc) Study: Diagnosis Year 2021 (Prostate Cancer and Ovarian Cancer)
Deadline : 23 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 97009333
Document Ref. No. : 75N91023Q00142
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Amendment 1 of the Solication attached.
Amendment 1 extends the Due Date for Submission of Quotes to February 23, 2024, 5:00PM EST. It also provides Answers to Solicitations Questions.
Quoters are required to acnowledge each Solicitation Amendment by including each Standard Form (SF-30) signed by your organizations signature authority and completing Block 8 with your Organization Name and Address, and submitting it along with your quote submission.
****************************************************************************************
The purpose of this acquisition is to collect data for the National Cancer Institute (NCI) Patterns of Care (POC) FY2024 Study. The NCI Pattern of Care studies describe, characterize, and compare practice patterns and treatments provided for cancer in different geographic areas of the United States. This solicitation for the FY 2024 NCI Patterns of Care Study is investigating patterns of care for patients with prostate and ovarian cancers for Diagnosis Year 2021. The study will also collect data on documentation of palliative care and patient financial impacts of the COVID-19 pandemic in the medical record.
The primary objectives of this POC Study are to:
1) describe the use of recommended biomarker tests which shall be verified with the treating physician/physician office staff or with a unified medical record (record with all inpatient and outpatient records in a single file) or complete medical records (all inpatient and outpatient cancer treatment records obtained from more than one hospital/healthcare system/medical practice);
2) describe the use of targeted therapy which shall be verified with the treating physician/physician office staff or with a unified or complete medical record.
3) describe the use of adjuvant therapy, which shall be verified with the treating physician/physician office staff or with a unified or complete medical records;
4) characterize the practice pat...
Active Contract Opportunity Notice ID 75N91023Q00142 Related Notice HHS-NIH-NCI-SBSS-NBB-0142-AM Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NIH NCI
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Feb 15, 2024 06:33 pm EST
Original Published Date: Feb 02, 2024 02:04 pm EST
Updated Date Offers Due: Feb 23, 2024 05:00 pm EST
Original Date Offers Due: Feb 20, 2024 03:00 pm EST
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Mar 09, 2024
Original Inactive Date: Mar 06, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: R702 - SUPPORT- MANAGEMENT: DATA COLLECTION
NAICS Code: 541990 - All Other Professional, Scientific, and Technical Services
Place of Performance: USA
Documents
Tender Notice
Amendment-0001_executed.pdf
RFQ-75N91023Q00142-w-attachments_FINAL-2-Feb-2024.pdf
ATT-2--Deliverables.docx
ATT-7--Additional-Quote-Instruct_2.1.24-FINAL.docx
ATT-8--SumRelatedActivities.docx